ACAM2000

Search documents
Emergent BioSolutions(EBS) - 2025 Q1 - Earnings Call Transcript
2025-05-07 22:02
Emergent BioSolutions (EBS) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Company Participants Frank Vargo - VP - Assistant TreasurerJoseph Papa - CEO, President & DirectorRichard Lindahl - EVP, CFO & TreasurerYi Chen - Managing Director, Equity Research Conference Call Participants Jessica Fye - Managing Director & Equity Research Analyst - Biotechnology Operator Good day, and thank you for standing by. Welcome to the First Quarter twenty twenty five Emergent BioSolutions, Inc. Earnings Conference Call. A ...
Emergent BioSolutions(EBS) - 2025 Q1 - Earnings Call Transcript
2025-05-07 22:00
Emergent BioSolutions (EBS) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Speaker0 Good day, and thank you for standing by. Welcome to the First Quarter twenty twenty five Emergent BioSolutions, Inc. Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. Please be advised that today's conference is being recorded. I wo ...
Emergent BioSolutions(EBS) - 2025 Q1 - Earnings Call Presentation
2025-05-07 21:04
Q1 2025 Financial Results May 7, 2025 1 Safe Harbor Statement/Trademarks There are a number of important factors that could cause our actual results to differ materially from those indicated by such forward-looking statements, including, among others, the availability of USG funding for contracts related to procurement of our medical countermeasure ("MCM") products, including CYFENDUS® (Anthrax Vaccine Adsorbed (AVA) Adjuvanted), previously known as AV7909, and ACAM2000® (Smallpox (Vaccinia) Vaccine, Live), ...
Emergent BioSolutions(EBS) - 2024 Q4 - Earnings Call Transcript
2025-03-04 00:58
Emergent BioSolutions Inc. (NYSE:EBS) Q4 2024 Earnings Conference Call March 3, 2025 6:00 AM ET Company Participants Frank Vargo - Assistant Treasurer Joseph Papa - President and Chief Executive Officer Richard Lindahl - Executive Vice President, Chief Financial Officer and Treasurer Conference Call Participants Nick Richitt - JPMorgan Brandon Folkes - Rodman & Renshaw Operator Good day, and thank you for standing by. Welcome to Emergent BioSolutions Inc. Fourth Quarter 2024 Earnings Conference Call. At thi ...